1-3 of 3
Julie G. Izzo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer

Kazuhiko Shien, Vassiliki A. Papadimitrakopoulou, Dennis Ruder, Carmen Behrens, Li Shen, Neda Kalhor, Juhee Song, J. Jack Lee, Jing Wang, Ximing Tang, Roy S. Herbst, Shinichi Toyooka, Luc Girard, John D. Minna, Jonathan M. Kurie, Ignacio I. Wistuba, Julie G. Izzo
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (10): 2234–2245.
https://doi.org/10.1158/1535-7163.MCT-17-0148
Published: 02 October 2017
View article titled, JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer
Open the PDF for JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras

Yanan Yang, Marie Wislez, Nobukazu Fujimoto, Ludmila Prudkin, Julie G. Izzo, Futoshi Uno, Lin Ji, Amy E. Hanna, Robert R. Langley, Diane Liu, Faye M. Johnson, Ignacio Wistuba, Jonathan M. Kurie
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 952–960.
https://doi.org/10.1158/1535-7163.MCT-07-2045
Published: 15 April 2008
View article titled, A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant <em>K-ras</em>
Open the PDF for A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant <em>K-ras</em> in another window
Journal Articles

Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma

Julie G. Izzo, Arlene M. Correa, Tsung-Teh Wu, Usha Malhotra, Clifford K.S. Chao, Rajyalakshmi Luthra, Joe Ensor, Alexander Dekovich, Zhongxing Liao, Walter N. Hittelman, Bharat B. Aggarwal, Jaffer A. Ajani
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (11): 2844–2850.
https://doi.org/10.1158/1535-7163.MCT-06-0351
Published: 22 November 2006
View article titled, Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma
Open the PDF for Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma in another window